| Entry |
|
| Name |
Saroglitazar (USAN/INN) |
| Formula |
C25H29NO4S
|
| Exact mass |
439.1817
|
| Mol weight |
439.57
|
| Structure |

|
| Remark |
|
| Efficacy |
Peroxisome proliferator-activated receptor (PPAR) agonist |
| Comment |
Treatment of primary biliary cholangitis, non-alcoholic steatohepatitis and nonalcoholic fatty liver disease in women with polycystic ovary syndrome
|
| Target |
|
| Pathway |
| hsa04920 | Adipocytokine signaling pathway |
| hsa04932 | Non-alcoholic fatty liver disease |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C (PPAR)
D13044 Saroglitazar (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 31
1 C8y C 23.8700 -13.5100
2 C8x C 23.8700 -12.1100
3 C8x C 25.0600 -11.4100
4 C8y C 26.3200 -12.1100
5 C8x C 26.3200 -13.5100
6 C8x C 25.0600 -14.2100
7 O2a O 22.6800 -14.2100
8 C1b C 21.4900 -13.5100
9 C1b C 20.3000 -14.2100
10 N4y N 19.1100 -13.5100
11 C8y C 17.8500 -14.0700
12 C8x C 16.9400 -13.0900
13 C8x C 17.5700 -11.9000
14 C8y C 18.9700 -12.1800
15 C1a C 19.9500 -11.2000
16 C8y C 17.5700 -15.4700
17 C8x C 18.6200 -16.3800
18 C8x C 18.3400 -17.7800
19 C8y C 17.0100 -18.2000
20 C8x C 15.8900 -17.2200
21 C8x C 16.2400 -15.8900
22 S2a S 16.7300 -19.6000
23 C1a C 15.4000 -20.0200
24 C1b C 27.5100 -11.4100
25 C1c C 28.7000 -12.1100
26 C6a C 29.8900 -11.4100
27 O2a O 28.7000 -13.5100
28 C1b C 29.8900 -14.2100
29 C1a C 31.0800 -13.5100
30 O6a O 31.0800 -12.1100
31 O6a O 29.8900 -10.0100
BOND 33
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 10 14 1
16 14 15 1
17 11 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 16 21 1
24 19 22 1
25 22 23 1
26 4 24 1
27 24 25 1
28 25 26 1
29 25 27 1 #Up
30 27 28 1
31 28 29 1
32 26 30 1
33 26 31 2
|